Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 2—June 1998
Dispatch

Emergence of the M Phenotype of Erythromycin-Resistant Pneumococci in South Africa

Carol A. Widdowson and Keith P. Klugman
Author affiliations: South African Institute for Medical Research, Johannesburg, South Africa

Main Article

Table 2

Serotype distribution among erythromycin-resistant pneumococci

Serotype/ group No. (%) of
MLSa isolates No. (%) of
M isolates Total no.
(%) of isolates
14 96 (39.8) 9 (31.0) 105 (38.9)
6 71 (29.5) 3 (10.3) 74 (27.4)
19 36 (14.9) 3 (10.3) 39 (14.4)
23 26 (10.8) 10 (34.5) 36 (13.3)
1 7 (2.9) 1 (3.5) 8 (3.0)
Other 5 (2.1) 3 (10.3) 8 (3.0)
Total 241 29 270

aMLS, macrolides-lincosamides-streptogramin B.

Main Article

Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external